人工机械瓣膜置换术后低强度抗凝治疗

Low Intensity Anticoagulant Therapy after Prosthetic Mechanical Valve Replacement

人工机械瓣膜置换术术后患者往往需要终身服用药物抗凝治疗,而抗凝治疗强度与患者凝血功能情况和后期是否发生出血或栓塞并发症关系密切。对于术后患者来说制定合理抗凝目标至关重要,本文通过探讨低强度抗凝治疗在人工机械瓣膜置换术术后患者身上的发展及应用,做一综述,希望本文能对心脏机械瓣膜置换术后患者的低强度抗凝治疗提供理论支持。

Patients after prosthetic mechanical valve replacement often require lifelong pharmacological anticoagulation therapy, and the intensity of anticoagulation therapy is closely related to the coagulation status of patients and whether bleeding or embolic complications occur. It is very important for postoperative patients to formulate reasonable anticoagulant goals. This paper discusses the development and application of low-intensity anticoagulant therapy in patients after prosthetic mechanical valve replacement. It is hoped that this paper can provide theoretical support for low-intensity anticoagulant therapy after mechanical heart valve replacement.